Live feed07:45:06·5mANALYSTRatingvia QuantisnowH.C. Wainwright reiterated coverage on Neumora Therapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.NMRA· Neumora Therapeutics Inc.Health CareOriginal source